Quinn Opportunity Partners »

Horizon Therapeutics shares owned by Quinn Opportunity Partners

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Quinn Opportunity Partners from 13F filings

Historical chart of Quinn Opportunity Partners investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Quinn Opportunity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Quinn Opportunity Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.5M 13k 115.69
2023-06-30 $39M 382k 102.85
2023-03-31 $31M 284k 109.14

More positions owned by Quinn Opportunity Partners

Biontech Se- Sponsored Ads (BNTX)
Citigroup Com New (C)
Verizon Communications (VZ)
First Citizens Bcshs -cl A Cl A (FCNCA)
At&t (T)
Ubs Group Ag-reg SHS (UBS)
Wells Fargo & Company (WFC)
First Horizon National Corporation (FHN)
Peloton Interactive Inc-a Cl A Com (PTON)
Barclays Plc-spons Adr (BCS)
Hawaiian Electric Industries (HE)
Meta Platforms Inc-class A Cl A (META)
Howard Hughes Holdings (HHH)
CVS Caremark Corporation (CVS)
Lyft Inc-a Cl A Com (LYFT)

View all positions for Quinn Opportunity Partners

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics